| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Mosseri Marlio Charles serves as a 10% Owner at NVCT. Across recent SEC filings that breaks down to 38 buys and 0 sells. Those positions are worth an estimated $71.5M at current prices.
Historically, Mosseri Marlio Charles's trades have earned a below-average insider score of 46/100 across 31 rated trades. Over a 12-month horizon, 24.0% of those trades were profitable, with an average 12-month return of -35.9%.
The biggest single holding is NVCT (~$71.5M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 764,217 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 1,556 | $13.98 | $21,752.88 | - | -36.3% | -50.7% | |
| Jul 26, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 10,000 | $13.97 | $139,700.00 | +0.4% | -34.8% | -52.2% | |
| Jul 21, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 8,238 | $14.47 | $119,224.44 | +0.2% | -39.6% | -55.3% | |
| Jul 19, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 8,000 | $14.84 | $118,720.00 | +0.3% | -34.2% | -55.0% | |
| Jul 18, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 9,149 | $14.84 | $135,771.16 | +0.4% | -27.1% | -54.0% | |
| Jul 12, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 3,285 | $15.09 | $49,570.65 | +0.1% | -28.7% | -57.5% | |
| Jul 11, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 10,000 | $15.36 | $153,600.00 | +0.4% | -29.0% | -59.3% | |
| Jul 7, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 8,948 | $15.19 | $135,920.12 | +0.4% | -28.7% | -59.4% | |
| Jul 6, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 3,179 | $15.01 | $47,716.79 | +0.1% | -27.5% | -59.3% | |
| Jul 5, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 1,176 | $15.52 | $18,251.52 | - | -29.5% | -60.9% |